newsfilter
← Latest News
Business Wire·

Syros Announces Voluntary Delisting from Nasdaq and SEC Deregistration

Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) (the "Company") today announced that its Board of Directors (the "Board") has approved and the Company intends to proceed with the voluntary delisting of its common stock from